{"id":"2827fc5afc85","type":"article","url":"https://hartvaat.nl/2018/07/01/hypertensie-bij-hiv-nieuwe-pathofysiologische-mechanismen/","title":"Hypertensie bij HIV: nieuwe pathofysiologische mechanismen","title_en":"Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms.","category":"hypertensie","category_label":"Hypertensie","professions":["cardioloog","internist"],"tags":[],"journal":"Hypertension (Dallas, Tex. : 1979)","doi":"10.1161/HYPERTENSIONAHA.118.10893","source_url":"https://doi.org/10.1161/HYPERTENSIONAHA.118.10893","authors":["Sasha A Fahme","Gerald S Bloomfield","Robert Peck"],"significance":6,"published":"2018-07-01","source_date":"2018-07-01","image":"","kennis":["https://hartvaat.nl/kennis/nierziekte/nierziekte-en-cardiovasculair-risico/","https://hartvaat.nl/kennis/hypertensie/hypertensie-en-diabetes/"],"congress":"","summary_en":"This review discussed the novel pathophysiological mechanisms underlying hypertension in HIV-infected adults, including immune activation, antiretroviral drug effects, and metabolic dysfunction unique to the HIV population.","created":"2026-07-03T10:27:21Z","updated":"2026-07-03T13:26:36Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Review over hypertensie bij HIV-patiënten met bespreking van nieuwe pathofysiologische mechanismen. Relevant gezien de toenemende cardiovasculaire belasting bij HIV.","abstract_original":""}